News
Increase in Hematocrit During Empagliflozin Treatment in a Diabetic Patient with Severe Anemia − A Case Study
In a case study involving a 78-year-old diabetic patient, where only the administration of empagliflozin led to the correction of severe anemia of unknown origin, Polish authors demonstrate the previously described pleiotropic effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i, i.e., gliflozins) on increasing hematocrit levels.
Composition of the Intestinal Microbiota of Patients with IBS May Predetermine the Success of a Diet with Low Fermentable Carbohydrates
Some patients with irritable bowel syndrome may benefit from a diet low in fermentable…
Can the use of sartans reduce mortality and severity of COVID-19 in hypertensives?
Existing scientific and clinical evidence suggests the involvement of the renin-angiotensin-aldoste…
Diagnosis of Skin Malignancies via Mobile Application Successfully Tested in the UK
Skin malignancies are a significant global cause of morbidity and mortality, with melanoma…
Early Detection of Erectile Dysfunction in Men with Type 2 Diabetes
A retrospective study published last year identified predictors of erectile dysfunction in men with…
Inosine Pranobex in the Treatment of Cervical HPV Infections
The aim of the review article published in the journal Infection and Drug Resistance was to…
Influence of ARNI on the Efficacy and Safety of Empagliflozin in the Treatment of Heart Failure with Reduced Ejection Fraction
Pharmacological inhibition of neprilysin and the AT1 receptor for angiotensin II (ARNI) through…
Autonomic Dysfunction in Patients with Transthyretin Amyloidosis
Autonomic nervous system disorders are a common complication of transthyretin amyloidosis. Their…
Overview of Current Treatment Options for MRSA-Induced Pneumonia
Pneumonia caused by methicillin-resistant strains of Staphylococcus aureus (MRSA) remains a disease…
Postoperative Bleeding in Children with Hypofibrinogenemia Induced by Cardiopulmonary Bypass
Patients undergoing cardiac surgery with the use of cardiopulmonary bypass are at risk of up to a…